AGT and pulmonary arterial hypertension: Exposing pulmonary endothelial cells to angiotensin I revealed a significatly increased angiotensin II production by cells isolated from PAH patients compared to control, which was abolished with the angiotensin-converting enzyme (ACE) inhibitor enalapril [12].